Lee Po-Feng, Li Chung-Yi, Liu Yen-Chin, Chiu Chang-Ta, Hou Wen-Hsuan
Department of Public Health, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan.
Jianan Psychiatric Center, Ministry of Health and Welfare, Tainan 717, Taiwan.
Healthcare (Basel). 2021 Oct 20;9(11):1402. doi: 10.3390/healthcare9111402.
(1) Background: The prevalence of opioid use in Taiwan increased by 41% between 2002 and 2014. However, little is known regarding the risk of mortality among long-term opioid analgesics users who do not have cancer. This study investigated this mortality risk with an emphasis on the calendar year and patients' age and sex. (2) Methods: This retrospective cohort study included 12,990 adult individuals without cancer who were long-term users of opioid analgesics and were randomly selected from the data set of Taiwan's National Health Insurance program from 2000 to 2012. They were then followed up through 2013. Information on the underlying causes of death was retrieved from the Taiwan Death Registry. Age, sex, and calendar year-standardized mortality ratios (SMRs) of all-cause and cause-specific mortality were calculated with reference to those of the general population. (3) Results: With up to 14 years of follow-up, 558 individuals had all-cause mortality in 48,020 person-years (cumulative mortality: 4.3%, mortality rate: 11.62 per 1000 person-years). Compared with the general population, the all-cause SMR of 4.30 (95% confidence interval (95% CI): 3.95-4.66) was significantly higher: it was higher in men than in women, declined with calendar year and age, and was significantly higher for both natural (4.15, 95% CI: 3.78-4.53) and unnatural (5.04, 95% CI: 3.88-6.45) causes. (4) Conclusions: Long-term opioid analgesics use among individuals without cancer in Taiwan was associated with a significantly increased risk of mortality. The notably increased mortality in younger adults warrants attention. Strategies to reduce long-term opioid analgesics use, especially their overuse or misuse, are in an urgent need.
(1) 背景:2002年至2014年间,台湾地区阿片类药物的使用患病率增长了41%。然而,对于非癌症长期使用阿片类镇痛药患者的死亡风险知之甚少。本研究调查了这一死亡风险,重点关注历年情况以及患者的年龄和性别。(2) 方法:这项回顾性队列研究纳入了12990名无癌症的成年阿片类镇痛药长期使用者,他们是从2000年至2012年台湾国民健康保险计划的数据集中随机选取的。随后对他们进行随访至2013年。从台湾死亡登记处获取死亡根本原因的信息。根据一般人群的情况计算全因死亡率和特定原因死亡率的年龄、性别及历年标准化死亡率(SMR)。(3) 结果:经过长达14年的随访,在48020人年中,有558人全因死亡(累积死亡率:4.3%,死亡率:每1000人年11.62人)。与一般人群相比,全因SMR为4.30(95%置信区间(95%CI):3.95 - 4.66),显著更高:男性高于女性,随历年和年龄下降,自然原因(4.15,95%CI:3.78 - 4.53)和非自然原因(5.04,95%CI:3.88 - 6.45)导致的死亡率均显著更高。(4) 结论:台湾地区无癌症个体长期使用阿片类镇痛药与死亡风险显著增加相关。年轻成年人中死亡率显著上升值得关注。迫切需要采取策略减少长期阿片类镇痛药的使用,尤其是其过度使用或滥用。